Nektar Therapeutics (NKTR) is the lead sponsor of 2 active clinical trials listed on ClinicalTrials.gov[2], including 2 Phase 2[1].
No Form 4 insider filings for NKTR were recorded at the SEC in the past 30 days[3].
NKTR is tracked by BiotechSigns with a current catalyst score of 39/100 and grade D. The page summarizes 0 active signals, including 0 PDUFA, 0 insider buying, and 0 clinical trial signals, with data refreshed on 2026-06-03.
Nektar Therapeutics (NKTR) is the lead sponsor of 2 active clinical trials listed on ClinicalTrials.gov[2], including 2 Phase 2[1].
No Form 4 insider filings for NKTR were recorded at the SEC in the past 30 days[3].